- Home
- PRPO vs ALBT Comparison
PRPO vs ALBT Comparison
Compare PRPO & ALBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPO
- ALBT
- Stock Information
- Founded
- PRPO N/A
- ALBT 2014
- Country
- PRPO United States
- ALBT United States
- Employees
- PRPO 57
- ALBT N/A
- Industry
- PRPO Biotechnology: Laboratory Analytical Instruments
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PRPO Industrials
- ALBT Health Care
- Exchange
- PRPO Nasdaq
- ALBT Nasdaq
- Market Cap
- PRPO 9.5M
- ALBT 2.9M
- IPO Year
- PRPO N/A
- ALBT N/A
- Fundamental
- Price
- PRPO $6.59
- ALBT $0.20
- Analyst Decision
- PRPO
- ALBT
- Analyst Count
- PRPO 0
- ALBT 0
- Target Price
- PRPO N/A
- ALBT N/A
- AVG Volume (30 Days)
- PRPO 7.9K
- ALBT 639.6K
- Earning Date
- PRPO 11-11-2024
- ALBT 11-12-2024
- Dividend Yield
- PRPO N/A
- ALBT N/A
- EPS Growth
- PRPO N/A
- ALBT N/A
- EPS
- PRPO N/A
- ALBT N/A
- Revenue
- PRPO $16,719,999.00
- ALBT N/A
- Revenue This Year
- PRPO $75.18
- ALBT N/A
- Revenue Next Year
- PRPO N/A
- ALBT N/A
- P/E Ratio
- PRPO N/A
- ALBT N/A
- Revenue Growth
- PRPO 52.61
- ALBT N/A
- 52 Week Low
- PRPO $4.31
- ALBT $0.16
- 52 Week High
- PRPO $8.99
- ALBT $1.44
- Technical
- Relative Strength Index (RSI)
- PRPO 52.82
- ALBT 42.61
- Support Level
- PRPO $6.42
- ALBT $0.16
- Resistance Level
- PRPO $6.99
- ALBT $0.30
- Average True Range (ATR)
- PRPO 0.33
- ALBT 0.03
- MACD
- PRPO -0.04
- ALBT 0.00
- Stochastic Oscillator
- PRPO 69.91
- ALBT 26.09
About PRPO Precipio Inc.
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.